Cynapsus Therapeutics Company
Cynapsus is a pharmaceutical company that focuses on developing a non-injectable drug for Parkinson–≤–Р–©s disease.
Investors Number:
3
Technology:
Biologics
Total Funding:
$23.8M
Founded Date:
2004
Headquarters:
Canada
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Equity
Investor Type:
For Profit
Funding Status:
M&A
Industry:
PharmTech